Literature DB >> 6521434

Deficiencies and improvement of methemoglobin assay.

J C Anders, H Chung.   

Abstract

A day-to-day variability in results was encountered when using the Dubowski method for the routine clinical determination of methemoglobin in blood. Therefore, studies were performed to determine the source(s) of variability in the method as described by Dubowski. It was determined that complete lysing of red blood cells is dependent upon both temperature of the buffer and the amount of lysing agent. Low buffer temperatures (less than 14 degrees C) produced highly variable results. This variability can be reduced by increasing the level of lysing agent to 40 mg per 20 mL of diluted blood. It was found that by using 37 degrees C buffer solution temperature and 40 mg Triton X-100 as lysing agent per 20 mL of diluted blood (1:20 with 0.25M sodium phosphate buffer, pH 7.4), the precision (percent coefficient of variation = 2%) and the accuracy (percent coefficient variation = 5.5%) were excellent.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6521434     DOI: 10.1093/jat/8.6.260

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  3 in total

1.  Effect of propolis on erythrocyte rheology in experimental mercury intoxication in rats.

Authors:  K Ercis; S Aydoğan; A T Atayoğlu; S Silici
Journal:  Environ Sci Pollut Res Int       Date:  2015-04-24       Impact factor: 4.223

2.  Simultaneous modeling of the pharmacokinetics and methemoglobin pharmacodynamics of an 8-aminoquinoline candidate antimalarial (WR 238605).

Authors:  R P Brueckner; L Fleckenstein
Journal:  Pharm Res       Date:  1991-12       Impact factor: 4.200

3.  Doxorubicin in vivo rapidly alters expression and translation of myocardial electron transport chain genes, leads to ATP loss and caspase 3 activation.

Authors:  Amy V Pointon; Tracy M Walker; Kate M Phillips; Jinli Luo; Joan Riley; Shu-Dong Zhang; Joel D Parry; Jonathan J Lyon; Emma L Marczylo; Timothy W Gant
Journal:  PLoS One       Date:  2010-09-15       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.